WLSI
Wellstar International, Inc. does not have significant operations. Previously, the company, through its subsidiary, Trillennium Medical Imaging, Inc., engaged in developing and licensing advanced thermal imaging technology in the consumer health care markets. Its technology enabled a diagnostic screening procedure for the early breast cancer detection; the differential diagnosis of pain dysfunctions, such as reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders; and the detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications. Wellstar International, Inc. was founded in 1997 and is based in Holland, Ohio.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2010 Q1 | -0.00 | $0 | -$288,183 |
| 2010 Q4 | -0.00 | $0 | -$389,180 |
| 2010 Q3 | -0.04 | $0 | -$254,152 |
| 2010 Q2 | 0.11 | $0 | -$371,322 |
| 2009 Q1 | 0.01 | $0 | -$288,571 |
| 2009 Q4 | -1.04 | $0 | -$185,825 |
| 2009 Q3 | -0.00 | $0 | -$191,487 |
| 2009 Q2 | -0.04 | $0 | -$236,519 |